India: Intellectual Property

The viewpoint of being able to provide cheap drugs to a population which cannot afford it has started yet another debate in the pharma sector about how drug companies should price the life saving drugs in the developing world.

In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.

In Scan Biotech India & Another v Scan Biotech India , Scan Biotech India & Another (Plaintiffs), a pharmaceutical product manufacturing concern sought permanent injunction against Scan Biotech India (Defendant) for their use of the trademark "BOLRAN" and the use of the trade name "SCAN BIOTEK INDIA".

The case of "Al-Hamd Tradenation vs Phonographic Performances Limited" centered on the issue of whether demanding exorbitant licensing fees constitutes a refusal under Section 31 of the Copyright Act, 1957, and whether such refusal would justify the grant of a compulsory license.

The Delhi High Court (‘DHC'), recently in the case of ANI Media Pvt Ltd v. Mohak Mangal & Ors., examined the interplay between copyright and trademark infringement, defamation...

Courts worldwide are faced with adjudicating complicated cases involving the nexus of AI and intellectual property law more frequently as generative artificial intelligence quickly changes how material...

The case of "Al-Hamd Tradenation vs Phonographic Performances Limited" centered on the issue of whether demanding exorbitant licensing fees constitutes a refusal under Section 31 of the Copyright Act, 1957, and whether such refusal would justify the grant of a compulsory license.

On 7 July 2025, FSSAI ordered every Licensing Authority to rigorously scrutinise the Annual Returns of Food Businesses Operators.

Research and Development (R&D) is the critical foundation and driver for innovation and the new product growth regime of many organisations, specifically in knowledge-intensive industries like pharmaceuticals and deep technology-enabled businesses.

This remarkable surge is the outcome of strategic policy reforms, sweeping digitisation measures, and sustained awareness campaigns undertaken by the Ministry of Commerce & Industry.

Quick on the heels of the Delhi High Court order (July 1, 2025) directing the South Korean Firm to Deposit INR 290 Crores (25% of the claimed damages of INR 1160 Crores) in Communication Components Antenna Inc. vs Ace Technologies Corp. & Ors.

As India's innovation landscape grows, the efficiency and reliability of its patent system have become more important than ever.